Cargando…
An approach to data collection in compassionate use/managed access
Compassionate Use (CU)/Managed Access programs provide access to locally unapproved medicines. As these programs become more global and involve a broader range of products, determining whether patients derive benefit from treatment could provide insights into therapeutic use in a real-word setting w...
Autores principales: | Sarp, Séverine, Reichenbach, Ramona, Aliu, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810195/ https://www.ncbi.nlm.nih.gov/pubmed/36605403 http://dx.doi.org/10.3389/fphar.2022.1095860 |
Ejemplares similares
-
Increasing Use of Compassionate Use/Managed Access Channels to Obtain Medicines for Use in COVID‐19
por: Aliu, Paul, et al.
Publicado: (2020) -
International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical Conditions
por: Aliu, Paul, et al.
Publicado: (2022) -
The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
por: Manivannan, Elangovan, et al.
Publicado: (2021) -
Compassionate Use of Yuanjiang Decoction, a Traditional Chinese Medicinal Prescription, for Symptomatic Bradyarrhythmia
por: Wan-Tong, Zhang, et al.
Publicado: (2022) -
Characterizing expanded access and compassionate use programs for experimental drugs
por: Miller, Jennifer E., et al.
Publicado: (2017)